Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | PHGDH | O43175 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25867515 | 0.77 | SMN1; SMN2 (0.43) | SMN1; SMN2CA12CA1CA9CA2 | |
| SCHEMBL14367203 | 0.74 | SMN1; SMN2 (0.41) | SMN1; SMN2CA12CA1CA9CA2 | |
| SCHEMBL20663399 | 0.71 | SMN1; SMN2 (0.38) | SMN1; SMN2CA12CA1CA9CA2 | |
| SCHEMBL26935700 | 0.69 | SMN1; SMN2 (0.39) | SMN1; SMN2CA12CA1CA9CA2 | |
| SCHEMBL23866149 | 0.69 | SMN1; SMN2 (0.44) | SMN1; SMN2CA12CA1CA9MAPT | |
| SCHEMBL19016208 | 0.68 | SMN1; SMN2 (0.50) | SMN1; SMN2CA12CA1CA9CA2 | |
| SCHEMBL27442057 | 0.68 | SMN1; SMN2 (0.50) | SMN1; SMN2CA12CA1CA9CA2 | |
| SCHEMBL16250021 | 0.67 | — | — | |
| SCHEMBL9419537 | 0.67 | ALDH1A1 (0.41) | SMN1; SMN2MAPTALDH1A1HTT | |
| SCHEMBL9419538 | 0.67 | ALDH1A1 (0.41) | SMN1; SMN2MAPTALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210238151-A1 | OXAZOLIDINONE HYDROXAMIC ACID DERIVATIVES | KUWAIT UNIVERSITY (KW) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238151-A1 | OXAZOLIDINONE HYDROXAMIC ACID DERIVATIVES | ALOX5, ALOX15, ALOX15B | SMN1; SMN2 4316/4885CA12 3123/4885CA1 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.